|Articles|August 14, 2008
Drug Designed to Fight MS Could Target Viral Infections
Advertisement
Reuters is reporting today that a new drug, FTY720, also called fingolimod, that Novartis AG is testing in individuals with multiple sclerosis could also tackle some viral infections, including perhaps including meningitis and perhaps even the AIDS virus. For the complete article,
Source: Reuters
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Infection Control Today
1
IP LifeLine: A Blessing in Disguise; Navigating a Job Loss in Infection Prevention
2
More Than One Path: Why Infection Prevention Needs the Voices of Non-RN Professionals
3
Nasal Microbiome Study Redraws the Map of Staphylococcus aureus Carriage
4
Copper-Embedded Textiles Show Promise in Reducing Microbial Burden and Supporting Infection Control
5
